Rapid Results…Real Impact!

LabNow Solutions is revolutionizing diagnostics through high-speed, decentralized
testing and AI-driven cancer screening, designed for speed, scalability, and clinical rigor.

Our Solutions Overview

Solution 1

High-Speed Diagnostic Point-of-Care (PoC) Platform – LabNow® Minilabs 

Purpose

Rapid, decentralized testing for emergency, outpatient, and rural healthcare settings.  

Key Features:

  • Quick Turnaround Time (TAT): Results in 2–15 minutes.
  • Regulatory Simplicity: CLIA-waived (U.S. FDA-approved), deployable in low-resource settings.
  • Embedded Intelligence: Integrated diagnostic algorithms for prognosis, error detection, and clinical decision support.
  • Versatile Test Menu: Infectious diseases, metabolic panels, respiratory assays (expandable).
  • Low Infrastructure Footprint: Compact, minimal training, no specialized lab personnel required.
  • Ideal For: Indian hospitals, diagnostic chains, and semi-urban clinics with limited lab capacity.

Solution 2

Algorithm-Driven Cancer Diagnostics with Patented Biomarkers  

Key Features:

  • High Sensitivity & Specificity: Early-stage detection (breast, lung, prostate cancers).
  • Cost Efficiency: Blood-based biomarkers enable affordable population-wide screening.
  • AI & Bioinformatics: Proprietary algorithms for risk stratification and disease progression prediction.
  • Cloud-Based Reporting: Enables remote diagnostics (ideal for Tier-2/3 cities).
  • Impact: Scalable, clinically rigorous, and economically viable cancer screening.

Our Technology Overview

Core Innovations

  • Partnerships: Collaborate with industry leaders in diagnostic equipment (USA-based, FDA/CE-approved).
  • Reference Installations: Deployed in Europe, USA, and other global markets.
  • Proprietary Tech: Multi-brand "best-in-breed" hardware/software integration.
  • IP Status: Patents pending/granted for key technologies.
  • Scalability: Modular platform design for flexible adoption.

Clinical Validation

  • LabNow® Minilabs:
  • PoCs, Pilot and commercial launch completed in USA and Europe
  • Endorsed by Indian healthcare Key Opinion Leaders (KOLs)
  • Cancer Diagnostics:
    • Pilot studies, trial results, and peer-reviewed publications available.  
    • Testimonials from Key Opinion Leaders (KOLs).

Key Differentiators

  • Speed: Fastest PoC diagnostics in the market (2–15 minutes).
  • Accessibility: CLIA-waived and low-infrastructure design.
  • Accuracy: AI-driven algorithms for error-free results.
  • Affordability: Cost-effective cancer screening via patented biomarkers.
  • Global Compliance: FDA/CE-approved technologies.

Call to Action

LabNow Solutions bridges the gap between cutting-edge diagnostics and real-world healthcare challenges through:  

  • LabNow® Minilabs for rapid decentralized testing.
  • AI-powered cancer diagnostics for early detection.

Next Steps